A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion

Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage

(2010) Sherrill J. Slichter et al.   NEW ENGLAND JOURNAL OF MEDICINE

An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment

(2010) Jean-Pierre Cazenave et al.   TRANSFUSION

Early recognition and reporting of suspected bacterial contamination may prevent transfusion transmission of infection by associated units

(2010) C. Cawley et al.   TRANSFUSION MEDICINE

Screening of platelets for bacterial contamination at the Welsh Blood Service

(2010) S. Pearce et al.   TRANSFUSION MEDICINE

Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use

(2009) Jean Claude Osselaer et al.   TRANSFUSION

BLOOD COMPONENTS: Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results

(2009) Larry J. Dumont et al.   TRANSFUSION

Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety

(2009) Anne F. Eder et al.   TRANSFUSION

Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment

(2008) Fabrice Cognasse et al.   TRANSFUSION

Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety

(2008) W. G. Murphy et al.   VOX SANGUINIS